Background: The present study evaluated the role of the CB2r in the regulation of depressive-like behaviors. To this aim, transgenic mice overexpressing the CB2r (CB2xP) were challenged against different types of acute and chronic experimental paradigms to evaluate its response to depressivelike behaviors. 
INTRODUCTION
The limited efficacy of current antidepressant treatments requires the development of alternative drugs. Recent pharmacological and genetic findings revealed the endocannabinoid system as a target closely related with the regulation of mood disorders. In fact, cannabinoid CB1 antagonists, SR141716A (rimonabant) and AM251, have presented antidepressant-like effects in animals models of depression (1) (2) (3) (4) . In addition, 5-HT, NA and dopamine levels in the prefrontal cortex increased after the administration of rimonabant (1;2;4;5). However, paradoxically rimonabant has been linked to increased risk of anxiety, depression and suicidal thoughts (6;7) in the treatment of depressive disorders in humans. Cannabinoid CB1 agonists and fatty acid amide hydrolase (FAAH) inhibitors induce antidepressant-like effects in the forced swimming test in rats (8) providing further support of a pivotal role of the endocannabinoid system in the pathogenesis of depression. Chronic treatment with these drugs promoted neurogenesis in hippocampus and enhanced central serotoninergic and noradrenergic transmission (9) . In addition, different animal models of depression revealed significant increases in CB1r density and function at the prefrontal cortex (10;11) that may be reversed by chronic fluoxetine treatment (10) . Clinically, significant up-regulation of CB1r density and CB1r-stimulated Gprotein activation was found in the prefrontal cortex of depressive suicide victims (12) .
Initially, CB2r was identified in the brain only under pathological conditions such as senile plaques in Alzheimer's disease (13) , in activated microglial cells/macrophages of multiple sclerosis (24) , amyotrophic lateral sclerosis spinal cord (14) and near to tumors (15;16) . Recently, CB2r were found under normal conditions in the brainstem of rat, mouse and ferret (17) . Further studies in the rat identified a wide distribution of CB2r in different brain areas including spinal nucleus, hippocampus, olfactory nucleus, cerebral cortex, amygdala, striatum, thalamus and cerebellum (18;19) . The presence of CB2r in these areas suggests its potential role in the regulation of anxiety and depression.
Interestingly, a reduction of CB2r in striatum, midbrain and hippocampus was reported in animal models of depression (20) . Conversely, intracerebroventricular microinjection of cannabinoid CB2 antisense oligonucleotide induced anxiolytic-like effects (21) . In addition, an association between cannabinoid CB2r polymorphism Q63R was also detected in Japanese depressed and alcoholic subjects (20) .
The responses of transgenic mice overexpressing this receptor (CB2xP) to acute and chronic anxiogenic-like stimuli were studied. The acute (the forced swimming test) and chronic (CMS María S. García-Gutiérrez 4 procedure) effects of AM630 were evaluated. Furthermore, the influence of CB2r on hippocampal neurogenesis was examined by studying BDNF expression in CB2xP and AM630-treated WT mice exposed to CMS.
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MATERIALS AND METHODS

Animals
Male mice overexpressing CB2r (CB2xP) made in our laboratory as described previously (33) 
Drugs
was obtained from Tocris (Biogen, Madrid, Spain) and dissolved in DMSO:Tween 80:distilled water were assigned to different groups, so the initial coat state and body weight were equivalent in all groups. Drug was given twice daily (9.00 and 18.00) at 1 mg/kg (i.p., 0.3 ml) during 4 weeks.
Behavioral analyses
Tail suspension test
Mice were individually suspended by the tail on the edge of a lever above the table top (distance from the floor was 35 cm) by using adhesive tape placed approximately 1-2 cm from the tip of the tail (24) . The time of immobility was measured during a period of 6 minutes. In this situation, mice develop escape-oriented behaviors interspersed with temporally increasing bouts of immobility.
Novelty suppressed feeding test
The testing apparatus consisted of a transparent methacrylate square cage 40 x 40 x 50 cm (37) .
At the time of testing, a single pellet of food was placed on a white paper platform in the center of the cage. Mice fasted for 24 hours, were individually placed in the corner of the apparatus. The time of latency to initiate consumption of the pellet was recorded to a ceiling of 5 minutes. Once the mice started to eat, the total amount of food pellet (g) was measured during a period of 5 minutes.
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Forced swimming test
The FST has been used as a model predictive of antidepressant action (38) . Briefly, each mouse was placed for 15 min in vertical Plexiglas cylinder (height 25 cm diameter 18 cm) containing water to a depth of 15 cm at 25±1 °C (25) . After 24 h, animals were placed again into the cylinder and the duration of the immobility was measured during a period of 5 min. Only active swimming, not floating movements, was taken into account for immobility measurement.
Chronic unpredictable mild stress
Mice were exposed to CMS during a period of 7-8 weeks (26;27). Mice were subjected several times per day to one or more of the following stressors: wet cage, food deprivation, restraint stress, period of stroboscopic illumination (150 flashes/min), inversion of light/dark cycle, tilted cage (45º) and strong noise (90-105 db). All the stressors and/or sequences were applied at different times point to avoid habituation and to provide an unpredictable feature to the stressors (Table 1) .
Sucrose consumption test
Sucrose intake (1% sucrose solution) was measured after 18 hours of food and water deprivation (28) . Consumption of sucrose solution was estimated simultaneously in control and experimental groups by comparing bottle weight before and after the 1-h window. The sucrose intake was expressed as mg sucrose/g body weight).
Analysis of BDNF gene expression
Brain sections were cut at 500 μm at different levels containing the regions of interest according to Paxinos and Franklin (29) , mounted onto slides and stored at −80 °C. Sections were dissected following the method described by Palkovits (30 
Immunohistochemistry
CB2xP and WT mice (n=3-5/group) were anesthetized with ketamine/xylacine ( 
Statistical analyses
Statistical analyses were performed using the Student t-test when comparing two groups and oneway or two-way analysis of variance followed by the Student Newman Keul's test when comparing three or four groups. Differences were considered significant if the probability of error was less than 5%. Data are presented as mean ± S.E.M. SigmaStat 3.1 software was used for all statistical analyses.
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RESULTS
Characterization of CB2r expression
Analysis of CB2r gene expression
The analyses of the different brain punches in WT mice by Rt-PCR revealed the presence of CB2r gene expression in almost all the nuclei examined. The results were expressed considering the CPu as 100% (arbitrarily). In this manner, CB2r gene expression resulted significantly higher in Acc (137%), Amy (107%), VMN (90%), Sn (224.62%) and MnR (84%) compared to CPu (n= 6-7/group) (see Table 2 and Figure 1A ). MnR t= 2.987, p= 0.014, 10 df) (n= 6-7/group) ( Figure 1A ).
3.1.2
The results revealed increased expression of CB2 protein in different fields of hippocampus (CA2, CA3 and DG) in CB2xP mice compared to WT mice (Student t-test CA2 t= 5.451, p= 0.002, 6 df ; CA3 t= 4.278, p= 0.005, 6 df; DG t= 3.937, p= 0.008, 6 df) (n= 4/group). No differences were detected in CA1 field (Student t-test t= 1.642, p= 0.152, 6 df) (n= 4/group) ( Figure 1B and 1C) .
CB2r protein expression in the hippocampus
Behavioral analyses
The effects of CB2xP and WT mice to acute and chronic anxiogenic-like stimuli were evaluated by using TST, NSFT and CMS tests. 
Analysis of BDNF in CB2xP and WT mice exposed to CMS
The expression of BDNF in the hippocampus, especially at the dentate gyrus (DG), is known to be down regulated in response to chronic stress (45) . In the present study, hippocampus BDNF gene expression of CB2xP and WT mice exposed to the CMS was measured by real-time PCR. As The effects of acute administration of AM630 on the response to anxiogenic-like stimuli were evaluated in CB2xP and WT mice by using the FST. The results revealed that AM630 increases = 7.381, p= 0.011) (n= 5-6/group) ( Figure 3 A2 and A3 ).
Acute and chronic effects of cannabinoid CB2 r antagonist
María S. García-Gutiérrez 11 significantly the time of immobility in WT mice at 1 and 3 mg/kg (one way ANOVA F (2,18) = 15.506, p<0.001) (n= 7-9 per group) ( Figure 4A , left panels). In contrast, this drug failed to produce any change in CB2xP mice (one way ANOVA F (2, 12) = 0.120, p= 0.888) (n= 6-8/group) ( Figure 4A , right panels).
In addition, the effects of chronic administration of AM630 on the response to anxiogenic-like stimuli were evaluated in WT mice exposed to CMS. Before administration of AM630, depressive-like behaviors were corroborated at different time points during CMS by using the TST (3rd week) and sucrose intake (4th week). The results revealed significant increased time of immobility in stressed- The effects of chronic anxiogenic-stimuli were examined exposing CB2xP mice to CMS. This animal model of depression involves the presentation of repeated unpredictable mild stressors for several weeks (34) (35) . Following such exposure, animals exhibited a persistent reduction in the responsiveness to pleasurable stimuli such as a palatable sucrose solution (36) (37) (38) . CMS produced depressive-like behavioral alterations in WT mice (reduced time of immobility in TST and sucrose intake). In contrast, exposure to CMS failed to produce any alteration in CB2xP mice. Interestingly, María S. García-Gutiérrez 14 CB2xP mice (under basal conditions) presented higher sucrose intake levels than WT mice. Although the precise mechanisms underlying these basal differences remain to be elucidated, it is tempting to speculate that CB2xP mice may present neuroendocrine and/or peripheral alterations that may be disrupting the homeostatic regulation of glucose, therefore modifying the appetite of these mice.
Exposure to CMS decreased neurogenesis and produced alterations of the remodeling dendrites process in hippocampus (39) (40) (41) (42) . In this respect, BDNF plays an important role in adult neurogenesis modulating plasticity and survival of adult neurons and glia cells (43) . Converging evidences revealed a reduction of hippocampal BDNF in rodents exposed to CMS (28;44-45) . Moreover, clinical studies showed a reduction of hippocampal neurogenesis in patients with mood disorders (46) (47) . In agreement with these findings, the results of this study revealed that CMS reduced hippocampal 
